1.Research progress of anatomical subsegmentectomy and combined subsegmentectomy in the treatment of early non-small cell lung cancer
Shao ZHOU ; Xiao ZHU ; Fubao XING ; Wei WANG ; Zhen TANG ; Lei ZHANG
Journal of Shenyang Medical College 2024;26(1):79-83
Lung cancer is one of the malignant tumors with the highest mortality and the fastest growing incidence,which seriously threatens human life and health.With the popularization of low-dose spiral CT and the enhancement of public awareness of physical examination,more and more ground-glass nodules have been detected.Accumulating studies have shown that for patients with nodules diameter≤2 cm and ground-glass opacity≥50% ,under the condition of ensuring the cutting edge,thoracoscopic sublobectomy or subsegmentectomy can more effectively preserve the lung function of patients,and has gradually become the recommended surgical method.In recent years,with the continuous improvement of thoracoscopic surgery technology,thoracoscopic subsegmentectomy and combined subsegmentectomy have been gradually carried out.Compared with lobectomy and segmentectomy,subsegmental resection can retain more normal lung tissue and reduce the loss of lung function under the condition of ensuring the safe cutting edge.However,thoracoscopic subsegmental resection requires a higher level of surgical technique and anatomical knowledge for the operator,and is rarely reported in relevant literature.Therefore,this article reviews the progress of anatomical subsegmentectomy and combined subsegmentectomy in the treatment of early non-small cell lung cancer.
2.Effect of thoraco-laparoscopic esophagectomy on postoperative immune function of patients with esophageal carcinoma.
Fubao XING ; Lei ZHANG ; Zhen TANG ; Xiaojun LI ; Huiyuan GONG ; Biao WANG ; Yannan HU
Journal of Southern Medical University 2021;41(1):146-150
OBJECTIVE:
To investigate the effect of thoraco-laparoscopic esophagectomy on postoperative immune function of patients with esophageal carcinoma.
METHODS:
Eighty-one patients undergoing radical esophagectomy in our hospital between January, 2017 and December, 2019 were enrolled in this study.According to the surgical approach, the patients were divided into endoscopic group (41 cases) and open surgery (3 incisions) group (40 cases).The immunological indicators (CD3
RESULTS:
No death occurred in either of the group after the operation.On days 4 and 7 after the operation, CD3
CONCLUSIONS
Thoraco-laparoscopic resection of esophageal cancer can reduce postoperative secretion of proinflammatory factors, alleviate inflammatory responses, and promote the recovery of immune functions to accelerate postoperative recovery of the patients.
Carcinoma, Squamous Cell/surgery*
;
Esophageal Neoplasms/surgery*
;
Esophagectomy
;
Humans
;
Laparoscopy
;
Postoperative Complications
;
Postoperative Period